Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease

Table 5

Rate of end-stage renal disease or dialysis in patients with monoclonal gammopathy.

	MGUS	SMM	MM	Amyloidosis	NHL	HL	Total
	(n = 92)	(n = 7)	(n = 44)	(=16)	(n = 12)	(n = 3)
CKD stages 1–4-n. (%)	57 (67.9)	5 (83.3)	21 (61.8)	11 (68.8)	6 (66.7)	3 (100)	103 (67.8)
CKD stage 5/dialysis-n. (%)	27 (32.1)	1 (16.7)	13 (38.2)	5 (31.3)	3 (33.3)	0 (3)	49 (32.2)

Missing data = 13%. CKD, chronic kidney disease; HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; MGUS, monoclonal gammopathy of indeterminate significance; MM, multiple myeloma; SMM, smoldering multiple myeloma.